# Multi-omics profiling reveals microenvironmental remodeling as a key driver of house dust mite-induced lung cancer progression

**Authors:** Shams Al-Azzam, Isabella Stuewe, Sunandini Sharma, Miki Yamada-Hara, Arisachi Tanaka, Kegan Stringer, Merna Behnam, Norah Al-Azzam, Shuvro Nandi, Maria Zhivagui, Janelle Duong, Ting Yang, Scott Herdman, Maripat Corr, Nicholas J. G Webster, Eyal Raz, Ludmil B Alexandrov, Samuel Bertin

PMC · DOI: 10.1016/j.neo.2026.101275 · 2026-01-28

## TL;DR

Chronic exposure to house dust mites promotes lung cancer by altering the lung's immune environment, not through DNA mutations.

## Contribution

The study identifies IL-17A as a key driver of HDM-induced lung tumor progression through immune remodeling.

## Key findings

- HDM exposure accelerates tumor growth without changing mutation rates.
- HDM suppresses T cell responses and promotes myeloid cell dominance in tumors.
- IL-17A is essential for HDM-driven tumor promotion, unlike IL-1β.

## Abstract

•Chronic house dust mite (HDM) exposure accelerates lung tumor growth through non-mutagenic, immune-mediated mechanisms.•HDM activates pro-inflammatory and immune programs in normal lung tissue but suppresses antitumor T cell responses in tumors.•Multi-omics profiling reveals epigenetic silencing of immune genes and a myeloid-enriched, lymphoid-deficient tumor microenvironment.•HDM-driven tumor promotion depends on IL-17A but not IL-1β, establishing IL-17A as a central driver of lung tumor promotion.

Chronic house dust mite (HDM) exposure accelerates lung tumor growth through non-mutagenic, immune-mediated mechanisms.

HDM activates pro-inflammatory and immune programs in normal lung tissue but suppresses antitumor T cell responses in tumors.

Multi-omics profiling reveals epigenetic silencing of immune genes and a myeloid-enriched, lymphoid-deficient tumor microenvironment.

HDM-driven tumor promotion depends on IL-17A but not IL-1β, establishing IL-17A as a central driver of lung tumor promotion.

Chronic exposure to the common aeroallergen house dust mite (HDM) induces lung inflammation and DNA damage, but its impact on lung cancer development remains largely unexplored. Using whole-genome sequencing, RNA-seq, and DNA methylation profiling, we assessed HDM effects in lung epithelial cell lines and a mouse orthotopic lung cancer model. HDM accelerated tumor growth without altering mutational burden. Transcriptomic and epigenetic analyses revealed tissue-specific effects: in normal lung, HDM enhanced pro-inflammatory and immune activation programs, whereas in tumors it suppressed T cell responses, antigen presentation, and chemokine signaling. Immune deconvolution showed a shift toward myeloid enrichment and lymphoid suppression, with reduced cytotoxic T and NK signatures. Notably, HDM-driven tumor promotion was abolished in Il17a−/− but not Il1b−/− mice, identifying IL-17A as a critical mediator. These findings demonstrate that chronic aeroallergen exposure reshapes the lung microenvironment to promote immune suppression and accelerate lung cancer progression.

Image, graphical abstract

## Linked entities

- **Genes:** IL17A (interleukin 17A) [NCBI Gene 3605], IL1B (interleukin 1 beta) [NCBI Gene 3553]
- **Proteins:** IL17A (interleukin 17A), IL1B (interleukin 1 beta)
- **Diseases:** lung cancer (MONDO:0005138)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Il33 (interleukin 33) [NCBI Gene 77125] {aka 9230117N10Rik, Il-33, Il1f11, NF-HEV}, Il18rap (interleukin 18 receptor accessory protein) [NCBI Gene 16174] {aka AcPL, IL-18R-beta, IL-18RAcP, IL-18Rbeta, IL-1RAcPL}, Ccl17 (C-C motif chemokine ligand 17) [NCBI Gene 20295] {aka Abcd-2, Scya17, Scya17l, Tarc}, Cxcl9 (C-X-C motif chemokine ligand 9) [NCBI Gene 17329] {aka CMK, Mig, MuMIG, Scyb9, crg-10}, Socs3 (suppressor of cytokine signaling 3) [NCBI Gene 12702] {aka Cis3, Cish3, EF-10, Ef10, SSI-3, Ssi3}, Tagln (transgelin) [NCBI Gene 21345] {aka Sm22, Sm22a, Ws310}, Mmp3 (matrix metallopeptidase 3) [NCBI Gene 17392] {aka EMS-2, MMP-3, SL-1, SLN-1, SLN1, STR-1}, Spi1 (Spi-1 proto-oncogene) [NCBI Gene 20375] {aka Dis-1, Dis1, PU.1, Sfpi-1, Sfpi1, Spi-1}, Aim2 (absent in melanoma 2) [NCBI Gene 383619] {aka Gm1313, Ifi210}, Igh-V (immunoglobulin heavy chain variable region) [NCBI Gene 16049] {aka B1H12, B4H2, Gal13, IGHV2B, M86}, Saa3 (serum amyloid A 3) [NCBI Gene 20210] {aka Saa-3, l7R3}, Bin2 (bridging integrator 2) [NCBI Gene 668218], Trem3 (triggering receptor expressed on myeloid cells 3) [NCBI Gene 58218] {aka TREM-3}, mt-Rnr1 (s-rRNA) [NCBI Gene 17724], Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, S100a9 (S100 calcium binding protein A9 (calgranulin B)) [NCBI Gene 20202] {aka 60B8Ag, BEE22, Cagb, GAGB, L1Ag, MRP14}, Tarm1 (T cell-interacting, activating receptor on myeloid cells 1) [NCBI Gene 245126] {aka 9930022N03Rik, Gm9904, OLT-2}, Lrrc25 (leucine rich repeat containing 25) [NCBI Gene 211228] {aka Mapa}, Ccl22 (C-C motif chemokine ligand 22) [NCBI Gene 20299] {aka ABCD-1, DCBCK, MDC, Scya22}, Tnfrsf4 (tumor necrosis factor receptor superfamily, member 4) [NCBI Gene 22163] {aka ACT35, CD134, Ly-70, Ox40, TXGP1L, Txgp1}, Gh (growth hormone) [NCBI Gene 14599] {aka Gh1, Ghb1}, Egfl7 (EGF-like domain 7) [NCBI Gene 353156] {aka VE-statin, Zneu1}, Il1 (interleukin 1 complex) [NCBI Gene 111343] {aka Il-1}, Stat1 (signal transducer and activator of transcription 1) [NCBI Gene 20846] {aka 2010005J02Rik}, LOC113791973 (peptidase 1) [NCBI Gene 113791973] {aka Der-p1, derp1}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Kras (Kras proto-oncogene, GTPase) [NCBI Gene 16653] {aka K-Ras, K-Ras 2, K-ras, Ki-ras, Kras-2, Kras2}, Fcgr2b (Fc receptor, IgG, low affinity IIb) [NCBI Gene 14130] {aka CD32, F630109E10Rik, Fc[g]RII, FcgRII, Fcgr2, Fcgr2a}, Tnfrsf14 (tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)) [NCBI Gene 230979] {aka Atar, HveA, Hvem, TR2, Tnfrs14}, Fcgr1 (Fc receptor, IgG, high affinity I) [NCBI Gene 14129] {aka CD64, FcgammaRI, IGGHAFC}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Gata3 (GATA binding protein 3) [NCBI Gene 14462] {aka Gata-3, jal}, Tnfrsf1a (tumor necrosis factor receptor superfamily, member 1a) [NCBI Gene 21937] {aka CD120a, FPF, TNF-R, TNF-R-I, TNF-R1, TNF-R55}, Syk (spleen tyrosine kinase) [NCBI Gene 20963] {aka Sykb}, Tnfrsf9 (tumor necrosis factor receptor superfamily, member 9) [NCBI Gene 21942] {aka 4-1BB, A930040I11Rik, CDw137, Cd137, ILA, Ly63}, Oas3 (2'-5' oligoadenylate synthetase 3) [NCBI Gene 246727] {aka Oasl10}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Tubb4a (tubulin, beta 4A class IVA) [NCBI Gene 22153] {aka M(beta)4, Tubb, Tubb4}, Il2rb (interleukin 2 receptor, beta chain) [NCBI Gene 16185] {aka CD122, IL-15Rbeta, IL15Rbeta, Il-2/15Rbeta, Il-2Rbeta, p70}, Ccl9 (C-C motif chemokine ligand 9) [NCBI Gene 20308] {aka CCF18, MRP-2, Scya10, Scya9}, Il1rn (interleukin 1 receptor antagonist) [NCBI Gene 16181] {aka F630041P17Rik, IL-1ra}, Fcgr3 (Fc receptor, IgG, low affinity III) [NCBI Gene 14131] {aka CD16}, Il1r2 (interleukin 1 receptor, type II) [NCBI Gene 16178] {aka CD121b, Il1r-2}, S100a8 (S100 calcium binding protein A8 (calgranulin A)) [NCBI Gene 20201] {aka 60B8Ag, B8Ag, CFAg, CP-10, Caga, MRP8}, Igk-V (immunoglobulin kappa chain complex variable region) [NCBI Gene 16080], Tnfsf9 (tumor necrosis factor (ligand) superfamily, member 9) [NCBI Gene 21950] {aka 4-1BB-L, 4-1BBL, Cd137l, Ly63l}, Prom2 (prominin 2) [NCBI Gene 192212] {aka Prom-rp}, Smad6 (SMAD family member 6) [NCBI Gene 17130] {aka Madh6, b2b390Clo}, Irak2 (interleukin-1 receptor-associated kinase 2) [NCBI Gene 108960] {aka 6330415L08Rik, IRAK-2}, Ripply3 (ripply transcriptional repressor 3) [NCBI Gene 170765] {aka Dscr6}, Tnfsf13b (tumor necrosis factor (ligand) superfamily, member 13b) [NCBI Gene 24099] {aka BAFF, BLyS, D8Ertd387e, TALL-1, TALL1, THANK}, Il4i1 (interleukin 4 induced 1) [NCBI Gene 14204] {aka Fig1, Fig1-ps, H-4, H-46, H4, H46}, Slfn8 (schlafen 8) [NCBI Gene 276950] {aka mSLFN8}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, Map3k7 (mitogen-activated protein kinase kinase kinase 7) [NCBI Gene 26409] {aka B430101B05, Tak1}, Il17ra (interleukin 17 receptor A) [NCBI Gene 16172] {aka Cdw217, Il17r, VDw217}, Lepr (leptin receptor) [NCBI Gene 16847] {aka B219, LEP-R, LEPROT, Leprb, Modb1, OB-RGRP}, Tril (TLR4 interactor with leucine-rich repeats) [NCBI Gene 66873] {aka 1200009O22Rik, mKIAA0644}, Btk (Bruton agammaglobulinemia tyrosine kinase) [NCBI Gene 12229] {aka xid}
- **Diseases:** LLC (MESH:D018827), Alzheimer's disease (MESH:D000544), Chronic inflammation (MESH:D007249), Amyotrophic lateral sclerosis (MESH:D000690), lung inflammation (MESH:D011014), lung carcinogenesis (MESH:D063646), lung (MESH:D008171), fungal (MESH:D009181), HDM (MESH:D000092542), non-small cell lung cancer (MESH:D002289), neurodegenerative diseases (MESH:D019636), hyperplasia (MESH:D006965), mitochondrial dysfunction (MESH:D028361), adenocarcinoma (MESH:D000230), H&amp;E (MESH:D016751), VEH (MESH:C536209), asthma (MESH:D001249), adenoma (MESH:D000236), Cancer (MESH:D009369), Diabetic Cardiomyopathy (MESH:D058065), lung cancer (MESH:D008175), tumorigenic (MESH:D002471)
- **Chemicals:** eosin (MESH:D004801), ROS (MESH:D017382), H&amp;E (MESH:D006371), penicillin (MESH:D010406), EDTA (MESH:D004492), ethanol (MESH:D000431), streptomycin (MESH:D013307), LPS (MESH:D008070), isoflurane (MESH:D007530), PBS (MESH:D007854), CO2 (MESH:D002245), paraffin (MESH:D010232), hematoxylin (MESH:D006416), d-luciferin (MESH:C532924), formalin (MESH:D005557), nitrogen (MESH:D009584), guanine (MESH:D006147), Canakinumab (MESH:C541220), urethane (MESH:D014520), CRL-1642 (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Ambrosia artemisiifolia (annual ragweed, species) [taxon 4212], Homo sapiens (human, species) [taxon 9606], Aspergillus (genus) [taxon 5052], Dermatophagoides pteronyssinus (European house dust mite, species) [taxon 6956]
- **Mutations:** C > A, C > G, T > A, C > T, T > G, M0348S, T > C
- **Cell lines:** LLC — Mus musculus (Mouse), Malignant tumors of the mouse pulmonary system, Cancer cell line (CVCL_4358), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), BEAS-2B — Homo sapiens (Human), Transformed cell line (CVCL_0168), VEH — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_UD94)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12874334/full.md

---
Source: https://tomesphere.com/paper/PMC12874334